Bone Support

Share Price

  • Contact Us
Follow
  • US site
    • Global English Site
    • Global Swedish Site
    • US site
  • Bonesupport
    • Message from the CEO
    • Vision & Mission
    • Sustainability
    • History
    • Management
    • The Board
    • Our Partners
    • Careers
  • Products
    • CERAMENT® BONE VOID FILLER
    • CERAMENT® G with Gentamicin
    • CERAMENT® BEAD TRAY
    • CERAMENT® Delivery Cannulas
    • Purchasing products
  • Innovation
    • Pipeline
    • CERTiFy Clinical Trial
  • Medical Professionals
    • TRAUMA: WHY USE CERAMENT®
    • BENIGN BONE TUMORS: WHY USE CERAMENT®
    • REVISION ARTHROPLASTY: WHY USE CERAMENT
    • FOOT AND ANKLE: WHY USE CERAMENT
  • Investors
    • Financials
    • Financial Reports
    • Presentations
    • The Share
    • Shareholders
    • Analyst Coverage
    • Corporate Governance
    • Calendar
    • Q&A
    • Definitions
  • Patients
    • Bone Grafts
    • BONE DEFECTS CAUSED BY TRAUMA
    • BONE DEFECTS CAUSED BY BENIGN BONE TUMORS
    • BONE DEFECTS CAUSED BY HIP AND KNEE REVISIONS
  • Media
    • Press Releases
    • Publications and Resources
    • Multimedia
    • Events
  • Contact Us
  • Global English Site
  • Global Swedish Site
  • US site
  • Financials
  • Financial Reports
  • Presentations
  • The Share
  • Shareholders
  • Analyst Coverage
  • Corporate Governance
  • Calendar
  • Q&A
  • Definitions

Financial Reports 2019

BONESUPPORT HOLDING AB was listed on Nasdaq Stockholm on 21st June 2017 and interim reports are published from Q2 2017.

PDF Icon

Annual Report 2019

03/04/2020

PDF Icon

Full Year Report 2019

26/02/2020

Net sales increased with 100 percent compared to previous year, and amounted to SEK 46.2 million (23.1). Gross margin amounted to 88.9 percent (85.0). Operating profit amounted to SEK -38.6 million (-45.0).
PDF Icon

Interim Report, Q3, July - September 2019

07/11/2019

Net sales amounted to SEK 39.1 million (14.2), an increase of 175%. Gross margin amounted to 87.7% (81.8). Operating profit totaled SEK -32.7 million (-58.4).
PDF Icon

Interim Report, Q2, April - June 2019

25/07/2019

Net sales amounted to SEK 37.3 million (28.2), an increase of 32%. Gross margin amounted to 86.5% (87.4). Operating profit totaled SEK -47.8 million (-37.8).
PDF Icon

Interim Report, Q1, January - March 2019

02/05/2019

Net sales amounted to SEK 32.8 million (31.1), an increase of 6%. Gross margin of 85.9% (82.1). Operating profit totaled SEK -39.0 million (-33.1).

©BONESUPPORT AB 2022. ALL RIGHTS RESERVED. CERAMENT and BONESUPPORT are registered Trademarks of BONESUPPORT AB.

  • Home
  • Contact Us
  • Privacy Policy
  • Cookie Policy